Statins for Smith-Lemli-Opitz syndrome
2020
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
1. To evaluate the efficacy of statin therapy in reducing the frequency or severity of the neurobehavioral abnormalities seen in people with SLOS (e.g. aggression, anxiety, irritability, self-mutilation, autistic behaviors, sleep disturbances, etc.) (Wassif 2017).
2. To evaluate the potential effects of statin therapy on survival.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
71
References
2
Citations
NaN
KQI